[권영주] Interrupting Specific Hydrogen Bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers


제목	[권영주] Interrupting Specific Hydrogen Bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers2022-09-28 18:36
카테고리	2022
LINK(PubMed) : J Adv Res . 2022 Aug 10;S2090-1232(22)00171-0 제 목 : Interrupting Specific Hydrogen Bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers 저 자 : Soo-Yeon Hwang, Seojeong Park, Hyunji Jo, Seung Hee Seo, Kyung-Hwa Jeon, Seojeong Kim, Ah-Reum Jung, Chanju Song, Misun Ahn, Soo Yeon Kwak, Hwa-Jong Lee, Motonari Uesugi, Younghwa Na, Youngjoo Kwon 저널명 : Journal of Advanced Research (IF=12.822) 게재년월 : 2022년 8월 DOI : 10.1016/j.jare.2022.08.003 ※ Impact Factor(IF)는 2021년 기준임

이전	[권영주] Identification of new halogen-containing 2,4-diphenyl indenopyridin-5-one derivative as a boosting agent for the anticancer responses of clinically available topoisomerase inhibitors
-	[권영주] Interrupting Specific Hydrogen Bonds between ELF3 and MED23 as an alternative drug resistance-free strategy for HER2-overexpressing cancers
다음	[권영주] Recent therapeutic trends and promising targets in triple negative breast cancer

FCC

EWHA WOMANS UNIVERSITY COLLEGE OF PHARMACY FIBROSIS CONTROL CENTER